Sonja Kallendrusch

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Patient Reported

Top Venues

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Siming Gong, Nikolas Schopow, Yingjuan Duan, Changwu Wu, Sonja Kallendrusch, Georg Osterhoff
PLOD Family: A Novel Biomarker for Prognosis and Personalized Treatment in Soft Tissue Sarcoma. Genes 13 (5) (2022)
Changwu Wu, Yingjuan Duan, Siming Gong, Georg Osterhoff, Sonja Kallendrusch, Nikolas Schopow
Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma. Cancers 14 (2) (2022)
David Junk, Sebastian Kraemer, Johannes Broschewitz, Hennig Laura, Chiara Massa, Yousef Moulla, Ngoc Anh Hoang, Astrid Monecke, Uwe Eichfeld, Ingo Bechmann, Florian Lordick, Barbara Seliger, Sonja Kallendrusch
Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibition. Cell death discovery 7 (1) (2021)
Marlon Hußtegge, Ngoc Anh Hoang, Jakob Rebstock, Astrid Monecke, Ines Gockel, Arved Weimann, Guido Schumacher, Ingo Bechmann, Florian Lordick, Sonja Kallendrusch, Justus Körfer
PD-1 inhibition in patient derived tissue cultures of human gastric and gastroesophageal adenocarcinoma. Oncoimmunology 10 (1) (2021)